DRKS00028521尚未招募Unknown
ongterm Intervention Study Allulose - LisA
Max Rubner-Institut0 个研究点目标入组 12 人开始时间: 2023年5月3日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •BMI 18,5 – 30 kg/m²
- •No intended weight change
- •Good general Health
- •Written informed consent to participate in the study
- •No diseases that affect nutrient absorption, digestion, metabolism or excretion, especially malabsorption or indigestion of fructose
- •Clinical parameters for liver and kidney function, carbohydrate and fat metabolism and inflammation markers indicating absence of disease
- •No indication of restrictive eating behavior (Dutch Eating Behavior Questionnaire (DEBQ))
- •Non- Smokers
- •No acute/regular intake of medication that affects fat or carbohydrate metabolism, or gastrointestinal tract
- •No intake of antibiotics in the prior 6 months
- •No pregnancy or lactation peroid
- •Absence of allergy / intolerance against any foods used in the study.
排除标准
- •Necessity to take certain medications during the study participation
- •Appearance of undesirable events
- •Appearance of acute diseases during the study participation
- •Revocation of consent to participate in the study
- •Non-compliance with the study protocol (including hygiene procedures)
研究者
相似试验
尚未招募
不适用
Cognitive effects for changes in appearance due to orthognathic surgeryJaw deformityJPRN-UMIN000046742Showa University20
已完成
不适用
ifestyle intervention studyE65-E68Obesity and other hyperalimentationDRKS00017819Technische Universität München272
尚未招募
Unknown
A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.CTRI/2023/06/054257CognitiveBotics Technologies Private Limited
招募中
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
进行中（未招募）
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40